Who Owns Clean & Clear?
Clean & Clear is owned by Johnson & Johnson, a publicly traded American multinational pharmaceutical and consumer goods company. Clean & Clear operates as Johnson & Johnson's acne treatment brand. Johnson & Johnson is headquartered in New Brunswick, New Jersey, USA and trades on NYSE under JNJ.
Parent Company
Johnson & Johnson
Founded
1993
Status
Publicly Traded
Headquarters
New Brunswick, New Jersey, USA
Who Owns Clean & Clear?
- Parent Company: Johnson & Johnson
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: JNJ
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Clean & Clear | Johnson & Johnson | Brand division |
History of Clean & Clear
- Founded: 1993
- Founders: Johnson & Johnson (internal development)
Clean & Clear was introduced by Johnson & Johnson in 1993 as a dedicated acne treatment brand targeting teenagers and young adults. The brand was developed in response to the growing need for effective, accessible acne solutions specifically formulated for teenage skin. Johnson & Johnson leveraged its skincare expertise to create a product line focused on oil control and blemish fighting. This founding vision demonstrated exceptional insight into the growing demand for specialized teenage skincare while establishing a distinctive approach to acne treatment that would define the category for generations.
The brand quickly gained market share in the acne treatment category, becoming one of the leading over-the-counter acne solutions for teenagers. Clean & Clear's product line expanded to include cleansers, spot treatments, and moisturizers specifically designed for acne-prone skin. The brand became known for its effective formulations and affordable pricing, making professional-grade acne treatment accessible to teenagers. This period of rapid growth demonstrated Clean & Clear's exceptional ability to scale operations while maintaining consistent brand positioning and quality standards that would define the brand for decades.
Throughout the 2000s and 2010s, Clean & Clear continued to innovate with new product formulations and delivery systems. The brand expanded its presence globally and introduced new product lines addressing different acne concerns and skin types. Clean & Clear maintained its focus on providing effective, affordable acne solutions for its target demographic. This strategic expansion demonstrated Clean & Clear's exceptional ability to adapt to changing skincare needs while maintaining its core commitment to accessible, effective acne treatment.
In recent years, Clean & Clear has continued to evolve with new formulations incorporating modern skincare science. The brand has expanded into related skincare categories while maintaining its core focus on acne treatment and oil control. Clean & Clear remains a leading acne treatment brand globally, particularly popular among teenagers and young adults. This continued evolution demonstrates Clean & Clear's exceptional ability to adapt to changing scientific advancements and consumer preferences while maintaining its core brand values and commitment to accessible, quality skincare solutions.
About Johnson & Johnson
Johnson & Johnson delivered exceptional 2025 results, with CEO Joaquin Duato describing it as a "catapult year" fueled by the strongest portfolio and pipeline in the company's history. Q4 2025 reported sales grew 9.1% to $24.6 billion, with operational growth of 7.1% and adjusted operational growth of 6.1%. Full-year 2025 sales reached $94.2 billion, up 6.0% year-over-year, demonstrating strong momentum across both business segments.
Financial Performance Overview shows Johnson & Johnson's remarkable growth trajectory. The company achieved extraordinary earnings growth with Q4 2025 EPS of $2.10 reported and $2.46 adjusted, while full-year 2025 EPS reached $11.03 reported and $10.79 adjusted. This performance reflects the effectiveness of Johnson & Johnson's strategic focus on innovation and operational excellence across its diverse healthcare portfolio.
Segment Performance demonstrated balanced growth across Johnson & Johnson's two main business segments. The Innovative Medicine segment achieved Q4 2025 sales of $15.8 billion, up 10.0% year-over-year with operational growth of 7.9%. The MedTech segment reached $8.8 billion in Q4 2025 sales, up 7.5% year-over-year with operational growth of 5.8%. For the full year, Innovative Medicine generated $60.4 billion in sales while MedTech contributed $33.8 billion, showing strong performance across pharmaceutical and medical device businesses.
Geographic Performance revealed robust growth across key markets. U.S. sales reached $14.2 billion in Q4 2025, up 7.5% year-over-year with operational growth of 7.5%. International markets achieved $10.4 billion in Q4 2025 sales, up 11.3% year-over-year with operational growth of 6.6%. For the full year, U.S. sales totaled $53.8 billion while international markets contributed $40.4 billion, demonstrating Johnson & Johnson's global reach and market penetration.
2026 Guidance reflects management confidence in continued growth momentum. Johnson & Johnson issued strong guidance for 2026, projecting estimated reported sales of $100.5 billion (6.7% growth at midpoint) and adjusted EPS of $11.53 (6.9% growth at midpoint). This guidance suggests continued strong performance across both Innovative Medicine and MedTech segments, supported by the company's robust pipeline and market-leading products.
Medical Innovation Achievements in 2025 were particularly noteworthy, highlighting Johnson & Johnson's leadership in developing breakthrough treatments. Significant innovations included the approval of CAPLYTA for major depressive disorder, representing a major advancement in mental health treatment. The company also secured approval for RYBREVANT FASPRO plus LAZCLUZE for non-small cell lung cancer, demonstrating continued leadership in oncology therapeutics.
Landmark Clinical Data further strengthened Johnson & Johnson's market position. The company reported landmark data for TECVAYLI plus DARZALEX FASPRO as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma. This clinical evidence supports Johnson & Johnson's position in treating complex hematological conditions and reinforces the company's reputation for developing innovative cancer therapies.
Strategic Acquisitions enhanced Johnson & Johnson's capabilities and pipeline strength. The acquisition of Halda Therapeutics during 2025 expanded the company's therapeutic capabilities and strengthened its pipeline of future medical breakthroughs across multiple therapeutic areas. This strategic acquisition demonstrates Johnson & Johnson's commitment to investing in innovative technologies and treatments that address unmet medical needs.
Surgical Technology Innovation marked Johnson & Johnson's expansion into advanced medical technology. The submission of the OTTAVA Robotic Surgical System represents the company's entry into the rapidly growing robotic surgery market, positioning Johnson & Johnson to compete with established players in minimally invasive surgical procedures. This innovation reflects the company's strategy of leveraging its medical expertise across multiple healthcare segments.
Operational Excellence contributed significantly to Johnson & Johnson's strong performance. The company achieved operational growth of 5.3% for the full year 2025, with adjusted operational growth of 4.2%, demonstrating effective management of costs and operational efficiency. This operational performance enabled Johnson & Johnson to convert revenue growth into strong earnings improvement and cash generation.
Research and Development Investment continued to drive Johnson & Johnson's innovation pipeline. The company's commitment to R&D investment, spending billions annually on pharmaceutical innovation and medical technology, has created a robust pipeline of future products across multiple therapeutic areas. This investment strategy has positioned Johnson & Johnson for sustained growth and market leadership in healthcare innovation.
Market Leadership Position was reinforced across multiple healthcare segments. Johnson & Johnson maintained dominant positions in oncology, immunology, neuroscience, cardiovascular, surgery, and vision care, with each of these six key therapeutic areas contributing to the company's overall growth and market presence. This diversified leadership reduces dependency on any single therapeutic area and provides multiple growth drivers.
Cash Generation and Financial Strength enabled Johnson & Johnson to pursue strategic initiatives while maintaining shareholder returns. The company generated approximately $19.7 billion in free cash flow for full year 2025, supporting strategic acquisitions, R&D investment, and capital returns to shareholders. This strong cash generation provides financial flexibility for future growth opportunities.
Regulatory Success in 2025 demonstrated Johnson & Johnson's ability to navigate complex regulatory environments and secure approvals for innovative treatments. The company's success in obtaining regulatory approvals for new indications and products reflects the strength of its clinical development programs and regulatory expertise.
Patient Impact remains central to Johnson & Johnson's mission and performance. The company's innovations in 2025, including new treatments for major depressive disorder and various cancers, directly impact patient lives and address critical unmet medical needs. This patient-centric approach drives both commercial success and fulfillment of Johnson & Johnson's broader healthcare mission.
Johnson & Johnson's 2025 performance demonstrates the effectiveness of its strategy focusing on medical innovation, operational excellence, and global market expansion. The combination of strong financial results, breakthrough innovations, and robust pipeline positions the company for continued leadership in the global healthcare industry.
- Founded: 1886
- Headquarters: New Brunswick, New Jersey, USA
- Company Type: Publicly Traded
- Stock: NYSE: JNJ
- Revenue: approximately $88.8 billion (FY2025)
- Employees: Approximately 131,000
Where Is Clean & Clear Made / Based?
- Headquarters: New Brunswick, New Jersey, USA
- Manufacturing / Operations: United States, Canada, Mexico, Europe, Asia
Clean & Clear Sustainability & Ethics
Clean & Clear operates under Johnson & Johnson's comprehensive sustainability framework, which addresses environmental responsibility, ethical business practices, and social impact within the consumer healthcare industry. As a skincare brand primarily serving teenagers and young adults, Clean & Clear's sustainability efforts focus on responsible formulations, ethical testing, and environmental stewardship.
Sustainable Formulation Development: Clean & Clear has implemented initiatives to develop more sustainable skincare formulations that minimize environmental impact while maintaining acne treatment effectiveness. The company has worked to reduce the environmental footprint of its products through biodegradable ingredients, reduced water usage in formulations, and elimination of harmful chemicals. Clean & Clear's formulation scientists focus on creating products that are effective against acne while being environmentally responsible.
Responsible Packaging Initiatives: Clean & Clear has implemented comprehensive packaging sustainability programs including reduced plastic usage, recycled content in packaging materials, and biodegradable alternatives. The company has redesigned its packaging to use less plastic overall, increased the percentage of recycled materials in its bottles and tubes, and implemented recycling-friendly packaging designs. Clean & Clear has set targets to make all packaging recyclable, reusable, or compostable by 2025.
Ethical Testing and Animal Welfare: Clean & Clear maintains strict ethical standards for product testing and has committed to eliminating animal testing where possible. The company invests in alternative testing methods including in-vitro testing, computer modeling, and human volunteer studies to reduce reliance on animal testing. Clean & Clear complies with all relevant regulations regarding animal testing and works with industry organizations to develop cruelty-free testing alternatives.
Environmental Manufacturing: Clean & Clear manufacturing facilities implement comprehensive sustainability measures including reduced water usage, energy-efficient production processes, and waste reduction programs. The company has invested in renewable energy sources for production facilities and implemented water conservation technologies that reduce water consumption in manufacturing processes. Clean & Clear's manufacturing sites maintain ISO 14001 environmental management certification.
Supply Chain Responsibility: Clean & Clear works with suppliers who demonstrate commitment to environmental and ethical standards. The company's supply chain includes raw material suppliers, packaging manufacturers, and distribution partners who must comply with environmental regulations and ethical labor practices. Clean & Clear conducts regular supplier audits and maintains comprehensive documentation of supply chain sustainability practices.
Community Engagement and Education: Clean & Clear participates in Johnson & Johnson's community initiatives focused on health education and youth empowerment. The company supports programs that provide skincare education to teenagers, promote healthy self-esteem, and address mental health issues related to acne and skin conditions. Clean & Clear's community engagement programs emphasize education about proper skincare and confidence building.
Product Safety and Transparency: Clean & Clear maintains strict standards for product safety and ingredient transparency. The company provides clear information about product ingredients, usage instructions, and potential side effects. Clean & Clear's commitment to transparency includes publishing safety data, conducting regular product testing, and maintaining open communication with consumers about product formulations and safety standards.
Climate Action and Carbon Reduction: Clean & Clear contributes to Johnson & Johnson's climate action goals by reducing carbon emissions across its operations. The company has implemented measures to reduce greenhouse gas emissions in manufacturing, transportation, and distribution. Clean & Clear has set targets to achieve carbon neutrality in its operations and works with suppliers to reduce carbon emissions throughout the supply chain.
Awards & Recognition
Clean & Clear has received recognition within the skincare and consumer healthcare industry for its effective acne treatment formulations and market leadership in the teenage skincare segment, though as a Johnson & Johnson brand, its accolades are often attributed to the parent company's overall skincare portfolio.
Acne Treatment Excellence: Clean & Clear has been recognized by dermatologists and skincare professionals for developing effective over-the-counter acne treatment formulations. The brand's products containing salicylic acid, benzoyl peroxide, and other active ingredients have been acknowledged for their efficacy in treating acne and improving skin clarity among teenage users.
Market Leadership Recognition: Clean & Clear has been acknowledged by market research organizations for its dominant position in the teenage acne treatment market. The brand's ability to maintain relevance with young consumers while competing against both established skincare brands and newer digital-native brands has been recognized as a significant achievement in the competitive skincare market.
Product Innovation Awards: Clean & Clear's development of innovative acne treatment formulations and delivery systems has received recognition from skincare industry organizations. The brand's advances in creating effective yet gentle formulations for teenage skin have been acknowledged for innovation in over-the-counter acne treatment technology.
Consumer Trust Awards: Clean & Clear has received recognition from consumer organizations for maintaining high standards of product safety and effectiveness. The brand's consistent quality and reliable performance in acne treatment have been acknowledged through consumer satisfaction awards and trust ratings from skincare review organizations.
Retail Partnership Recognition: Clean & Clear's relationships with major retailers and its success in the mass-market skincare segment have been acknowledged by retail industry organizations. The brand's ability to secure prominent shelf placement and maintain strong sales performance across various retail channels has been recognized as a significant achievement in consumer goods marketing.
Educational Impact Recognition: Clean & Clear's educational initiatives about acne treatment and skincare have been recognized by healthcare organizations and educational institutions. The brand's efforts to provide accurate information about acne causes, treatment options, and skincare best practices have been acknowledged for contributing to public health education.
Brand Loyalty Recognition: Clean & Clear has been recognized for building strong brand loyalty among teenage consumers, particularly through its consistent messaging and product performance. The brand's ability to maintain customer relationships through the transition from teenage to young adult skincare has been acknowledged as a significant achievement in brand management.
Clean & Clear Recalls & Controversies
Clean & Clear has maintained a relatively clean operational record throughout its history, with no major product recalls or significant controversies that have substantially damaged the brand's reputation or standing in the skincare industry.
Product Safety Record: Clean & Clear has maintained strong product safety standards throughout its history, with no major product recalls or safety incidents reported. The company's acne treatment products undergo rigorous testing and quality control processes to ensure they meet safety standards for over-the-counter skincare products. Clean & Clear's commitment to product safety has helped maintain consumer trust and brand reputation in the competitive acne treatment market.
Ingredient Safety Concerns: Clean & Clear has faced some scrutiny regarding certain ingredients commonly used in acne treatments, such as benzoyl peroxide and salicylic acid. The company has addressed these concerns by providing clear usage instructions, conducting safety studies, and maintaining compliance with FDA regulations for over-the-counter acne medications.
Marketing and Advertising Practices: Clean & Clear has faced some criticism regarding its marketing practices, particularly concerning before-and-after advertising claims and the portrayal of acne in marketing materials. The company has worked to ensure marketing claims are accurate and not misleading, while maintaining realistic expectations about product results.
Environmental Impact Concerns: Clean & Clear has faced scrutiny regarding the environmental impact of its products and packaging, particularly concerning plastic waste and chemical ingredients that may affect water systems. The company has responded by implementing sustainability initiatives and reducing the environmental footprint of its products and packaging.
Competition and Market Share: Clean & Clear has faced increasing competition from newer skincare brands, particularly those focusing on natural ingredients and digital marketing. These competitive challenges represent normal market dynamics rather than ethical or operational controversies.
Regulatory Compliance: Clean & Clear has maintained compliance with all relevant regulations governing over-the-counter skincare products in the markets where it operates. The company has not faced significant regulatory actions or compliance violations that have resulted in fines or operational restrictions.
Supply Chain Management: Clean & Clear has maintained ethical supply chain practices throughout its operations, working with suppliers who meet environmental and labor standards. The company has not faced significant controversies related to supply chain practices or manufacturing ethics.
Customer Satisfaction: Clean & Clear has maintained positive customer satisfaction ratings across its markets, with no major consumer complaints or quality issues that have impacted brand reputation. The brand's focus on effective acne treatment and affordable pricing has helped maintain consumer trust and loyalty.
Brands Owned by Johnson & Johnson
- Acuvue - Johnson & Johnson's contact lens brand, launched in 1988 as the world's first di...
- Aveeno - American brand of skincare and hair care products specializing in natural ingred...
- Band-Aid - American brand of adhesive bandages and wound care products manufactured and mar...
- Benadryl - American brand of antihistamine medication used to treat allergies, itching, and...
- Carefree - American brand of feminine hygiene liners and pads, manufactured and marketed by...
- Johnson's Baby - American brand of baby care products specializing in gentle formulations for inf...
- Motrin - American brand of ibuprofen pain relief medication owned by Kenvue, the consumer...
- Neosporin - American brand of antibiotic ointment and topical wound care products containing...
- Rembrandt - American brand of whitening toothpaste and oral care products specializing in te...
- RoC - American brand of dermatological skincare products specializing in anti-aging an...
- Stayfree - Feminine hygiene brand of pads and liners owned by Kenvue globally, with North A...
- Tylenol - American brand of pain relief medication and analgesic drugs, flagship product o...
- Zyrtec - American brand of cetirizine antihistamine medication used to treat allergies wi...
Clean & Clear Ownership: Pros & Cons
Advantages
- +Effective acne treatment formulations backed by Johnson & Johnson's research
- +Affordable pricing making professional-grade acne solutions accessible to teenagers
- +Wide product range addressing different acne concerns and skin types
- +Trusted brand reputation among teenagers and young adults
- +Strong presence in drugstores and mass retail channels
- +Oil-control formulations specifically designed for acne-prone skin
- +Backed by Johnson & Johnson's healthcare expertise and resources
Considerations
- -Some products may be harsh for sensitive or dry skin types
- -Competition from prescription acne treatments and dermatologist-recommended products
- -Some consumers prefer natural or gentler acne treatment alternatives
- -Product effectiveness varies depending on acne severity and individual skin type
- -May contain ingredients some consumers wish to avoid
- -Limited effectiveness for severe acne requiring professional dermatological treatment
Frequently Asked Questions About Clean & Clear
Sources & Further Reading
- Clean & Clear Official Website -
- Johnson & Johnson Corporate Information -
- Johnson & Johnson Investor Relations -
- NYSE: JNJ Johnson & Johnson Stock -
- FDA Over-the-Counter Acne Treatment Guidelines -
- American Academy of Dermatology: Acne Treatment -
- Skincare Ingredient Database -
- Consumer Healthcare Products Association -
- Sustainable Packaging Coalition -
- Environmental Working Group: Skincare -
- Johnson & Johnson Sustainability Report -
- Teen Skincare Market Research -
- Acne Treatment Clinical Studies -
- Cosmetic Ingredient Review -
- SEC Filings: Johnson & Johnson -
Where to Buy
Disclosure: We may earn commission from purchasesCompetitors to Clean & Clear
No direct competitors found in the same category. This could be because Clean & Clearoperates in a unique market segment or we're still building our competitor database.
Johnson & Johnson Stock Information
Jobs at Johnson & Johnson
Latest News About Clean & Clear
Related Articles About Clean & Clear
View more articlesWho Owns the Sunscreen Market
Beiersdorf owns Nivea Sun and Coppertone. L'Oreal owns La Roche-Posay and Anthelios. Edgewell owns Banana Boat and Hawaiian Tropic. Here is who controls the global sunscreen market in 2026.
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
People Also Searched
Discover popular brands and companies in the Beauty & Personal Care category and related searches from other users.

Accutane
Prescription dermatology medication containing isotretinoin for treating severe acne, originally developed by Roche. The brand-name Accutane was discontinued in the U.S. in 2009, though generic isotretinoin remains widely available.

Acqua di Parma
Italian luxury fragrance and grooming brand founded in Parma in 1916, owned by LVMH since 2001 and renowned for its signature Colonia fragrance.

Always
Procter & Gamble's feminine hygiene brand launched in 1983, holding approximately 27% global market share in menstrual pads and sold in more than 100 countries.